Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Frontiers in Veterinary Science|January 8, 2025
Cytokines as potential biomarkers for the diagnosis of Mycobacterium bovis infection in Mediterranean buffaloes (Bubalus bubalis)Giulia Franzoni, Federica Signorelli, Piera Mazzone, et al.
Veterinary Immunology and Immunopathology|August 14, 2024
Vaccination of cattle with a virus vector vaccine against a major membrane protein of Mycobacterium avium subsp. paratuberculosis elicits CD8 cytotoxic T cells that kill intracellular bacteriaAsmaa H Mahmoud, Gaber S Abdellrazeq, Valentina Franceschi, et al.
Vaccines|April 30, 2021
Evaluation of Safety and Efficacy of an Inactivated Marker Vaccine against Bovine alphaherpesvirus 1 (BoHV-1) in Water Buffalo (Bubalus bubalis)Stefano Petrini, Alessandra Martucciello, Francesco Grandoni, et al.
Tuberculosis (Edinburgh, Scotland)|April 22, 2026
Host transcriptional responses identify putative diagnostic biomarkers for bovine tuberculosis in cattle and buffaloFederica Signorelli, Caterina Marè, Giovanna De Matteis, et al.
The Journal of Allergy and Clinical Immunology|January 22, 2015
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levelsRoberta Zanotti, Carla Lombardo, Giovanni Passalacqua, et al.
Leukemia Research|January 14, 2015
The impact of sensitive KIT D816V detection on recognition of indolent Systemic MastocytosisGiovanna De Matteis, Roberta Zanotti, Sabrina Colarossi, et al.
Cancer Medicine|October 8, 2022
BCR::ABL1 levels at first month after TKI discontinuation predict subsequent maintenance of treatment-free remission: A study from the "GRUPPO TRIVENETO LMC"Sara Di Giusto, Eleonora Toffoletti, Massimiliano Bonifacio, et al.
The Journal of Allergy and Clinical Immunology|August 8, 2013
Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SMIván Alvarez-Twose, Roberta Zanotti, David González-de-Olano, et al.
Oncotarget|November 8, 2017
Baseline factors associated with response to ruxolitinib: an independent study on 408 patients with myelofibrosisFrancesca Palandri, Giuseppe Alberto Palumbo, Massimiliano Bonifacio, et al.
Oncotarget|April 22, 2017
Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratoriesMargherita Perricone, Francesca Palandri, Emanuela Ottaviani, et al.
Pageof 6